Abstract 372: VGF is functionally responsible for chemotherapy resistance in non-small cell lung cancer
Abstract Despite the success of immune checkpoint therapy, most non-small cell lung cancer (NSCLC) patients still receive conventional chemotherapy. Overcoming chemotherapy resistance by identifying specific targets should improve cancer treatment and patient survival. In this study, we examined a p...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 79; no. 13_Supplement; p. 372 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.07.2019
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!